GLP-1 COMPOSITIONS AND USES THEREOF
- 专利权人:
- Novo Nordisk A/S
- 发明人:
- Eva Horn Moeller,Michael Duelund Soerensen,Joakim Lundqvist
- 申请号：
- US16774666
- 公开号：
- US20200164042A1
- 申请日:
- 2020.01.28
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.
- 来源网站：
- 中国工程科技知识中心
